These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9056390)

  • 1. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity.
    Matthews RT; Yang L; Beal MF
    Exp Neurol; 1997 Feb; 143(2):282-6. PubMed ID: 9056390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
    Darvesh AS; Yamamoto BK; Gudelsky GA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel free radical spin traps protect against malonate and MPTP neurotoxicity.
    Matthews RT; Klivenyi P; Mueller G; Yang L; Wermer M; Thomas CE; Beal MF
    Exp Neurol; 1999 May; 157(1):120-6. PubMed ID: 10222114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.
    Yang L; Sugama S; Mischak RP; Kiaei M; Bizat N; Brouillet E; Joh TH; Beal MF
    Neurobiol Dis; 2004 Nov; 17(2):250-9. PubMed ID: 15474362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate.
    Beal MF; Henshaw DR; Jenkins BG; Rosen BR; Schulz JB
    Ann Neurol; 1994 Dec; 36(6):882-8. PubMed ID: 7998775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial stress-induced dopamine efflux and neuronal damage by malonate involves the dopamine transporter.
    Moy LY; Wang SP; Sonsalla PK
    J Pharmacol Exp Ther; 2007 Feb; 320(2):747-56. PubMed ID: 17090704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
    Cooper GR; Mialkowski K; Wolff DJ
    Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP.
    Andreassen OA; Ferrante RJ; Dedeoglu A; Albers DW; Klivenyi P; Carlson EJ; Epstein CJ; Beal MF
    Exp Neurol; 2001 Jan; 167(1):189-95. PubMed ID: 11161607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells.
    Koeberle PD; Ball AK
    Exp Neurol; 1999 Aug; 158(2):366-81. PubMed ID: 10415143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.
    Gomes MZ; Raisman-Vozari R; Del Bel EA
    Brain Res; 2008 Apr; 1203():160-9. PubMed ID: 18313645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
    Itzhak Y; Martin JL; Ali SF
    Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
    Volz TJ; Schenk JO
    Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo.
    Schulz JB; Matthews RT; Jenkins BG; Ferrante RJ; Siwek D; Henshaw DR; Cipolloni PB; Mecocci P; Kowall NW; Rosen BR
    J Neurosci; 1995 Dec; 15(12):8419-29. PubMed ID: 8613773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal nitric oxide synthase modulates basal catecholamine secretion in bovine chromaffin cells.
    Vicente S; González MP; Oset-Gasque MJ
    J Neurosci Res; 2002 Aug; 69(3):327-40. PubMed ID: 12125074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
    Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity.
    Klivenyi P; Andreassen OA; Ferrante RJ; Lancelot E; Reif D; Beal MF
    Neuroreport; 2000 Apr; 11(6):1265-8. PubMed ID: 10817604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase.
    Connop BP; Boegman RJ; Beninger RJ; Jhamandas K
    Neuropharmacology; 1996 Apr; 35(4):459-65. PubMed ID: 8793908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.